Company intelligence / Profile preview

Bluebell Capital Partners

London, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Bluebell Capital Partners is a London‑based European activist investment firm focused on large‑cap European public equities, aiming to invest in businesses trading at a discount to intrinsic value and increase shareholder value through constructive engagement, often with an ESG focus. It has been active as an activist shareholder in companies including Bayer.

Industry: Investors

Beyond the preview

Go deeper on Bluebell Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bluebell Capital Partners.

Explore the full profile